|
Effect of rosuvastatin on progression of CIMT in low-risk individuals with subclinical atherosclerosis: The METEOR Trial
Objectives: After completing this audio conference the participant should be better able to: 1) discuss the study design and rationale for the METEOR trial, 2) understand the place for CIMT measurements in risk prediction, 3) understand the argument for low-risk patient treatment, and 4) apply learnings to provide enhanced patient care.
Title: Effect of rosuvastatin on progression of carotid intima-media thickness in low-risk individuals with subclinical atherosclerosis: the METEOR Trial.
Authors: JR Crouse, JS Raichlen, WA Riley, GW Evans, MK Palmer, DH O'Leary, DE Grobbee, ML Bots
Citation: JAMA 2007 3;297(12):1344-53
|